Im Cannabis Corp (IMCC)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.05M
Last updated: Nov 17, 2026 at 11:05 AM ET
Im Cannabis Corp (IMCC) Financials: Revenue, Profit and Cash Flow
Im Cannabis reported revenue of CAD 54.73M for the fiscal year ended Dec 31, 2025, up 1.3% from the year before. That year, net income was CAD -11.32M with a net margin of -20.7%, operating cash flow was CAD 4.72M and free cash flow was CAD 4.70M. The quarter ended Jun 30, 2026 had revenue of CAD 7.59M and net income of CAD -4.36M.
Revenue and Margins
The operating margin was -21.2% in the fiscal year ended Dec 2025. Over the 8 years to Dec 2025, revenue grew from CAD 4.39M, a compound annual rate of 37.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 54.73M | +1.3% | 17.7% | -21.2% | -20.7% |
| Dec 2024 | 54.03M | +10.7% | 15.6% | -18.9% | -19.6% |
| Dec 2023 | 48.80M | -10.2% | 20.2% | -26.2% | -19.5% |
| Dec 2022 | 54.34M | +59.6% | 16.9% | -56.7% | -347.6% |
| Dec 2021 | 34.05M | +114.3% | 18.6% | -67.6% | -52.2% |
| Dec 2020 | 15.89M | +75.1% | 65.9% | -51.9% | -180.6% |
| Dec 2019 | 9.07M | +74.6% | 43.3% | -113.2% | -80.4% |
| Dec 2018 | 5.20M | +18.3% | 80.8% | 59.3% | 32.4% |
| Dec 2017 | 4.39M | N/A | 63.8% | -2.8% | -2.8% |
| Dec 2016 | N/A | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54.73M | 54.03M | 48.80M | 54.34M | 34.05M | 15.89M | 9.07M | 5.20M | 4.39M | N/A |
| Cost of revenue | 45.05M | 45.58M | 38.96M | 45.17M | 27.72M | 5.42M | 5.14M | 999.00K | 1.59M | N/A |
| Gross profit | 9.69M | 8.45M | 9.85M | 9.16M | 6.33M | 10.47M | 3.93M | 4.20M | 2.80M | N/A |
| Research and development | 0 | 0 | 0 | 0 | 11.00K | 136.00K | 233.00K | 83.00K | 0 | 0 |
| Operating income | -11.59M | -10.23M | -12.79M | -30.79M | -23.04M | -8.24M | -10.28M | 3.08M | -124.97K | -15.25K |
| Net income | -11.32M | -10.59M | -9.50M | -188.89M | -17.76M | -28.70M | -7.29M | 1.68M | -124.97K | -15.75K |
| EBITDA | -6.95M | -6.14M | -2.79M | -16.76M | 6.24M | -7.04M | -6.02M | 3.26M | -124.97K | -15.25K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.59M | 8.68M | 11.25M | 13.85M | 12.70M | 12.50M | 13.34M | 13.88M | 14.75M | 12.06M | 10.70M | 12.37M |
| Gross profit | 1.50M | 1.42M | 58.81K | 2.73M | 3.42M | 3.45M | 2.68M | 3.15M | 844.00K | 1.78M | 841.00K | 2.65M |
| Operating income | -2.09M | -1.68M | -2.82M | -4.15M | -350.00K | 158.00K | -19.69M | 953.00K | 2.87M | -5.63M | -5.17M | 2.26M |
| Net income | -4.36M | -2.28M | -5.47M | -3.65M | -309.00K | 275.00K | -1.01M | -922.00K | -3.03M | -5.62M | -3.29M | -2.15M |
Balance Sheet
As of Dec 2025, total debt of CAD 16.21M exceeded cash and equivalents by 13.49M. Shareholder equity was negative, at -858.00K, as total liabilities of 35.35M exceeded total assets of 31.74M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 31.74M | 39.19M | 48.81M | 60.68M | 287.39M | 38.12M | 30.89M | 37.00K | 9.14K | 276 |
| Current assets | 22.74M | 23.36M | 24.27M | 32.67M | 84.31M | 27.14M | 24.29M | 37.00K | 9.14K | 275 |
| Cash and equivalents | 2.73M | 863.00K | 1.81M | 2.45M | 13.90M | 8.88M | 13.93M | 37.00K | 4.03K | 170 |
| Total liabilities | 35.35M | 36.04M | 35.11M | 36.88M | 82.44M | 25.51M | 4.79M | 251.65K | 465.99K | 432.15K |
| Short-term debt | 15.28M | 17.38M | 12.57M | 10.06M | 11.06M | 167.00K | 159.00K | N/A | N/A | 6.44K |
| Long-term debt | 936.00K | 466.00K | 394.00K | 399.00K | 392.00K | N/A | N/A | N/A | N/A | N/A |
| Shareholder equity | -858.00K | 5.24M | 14.47M | 22.65M | 201.24M | 11.10M | 24.66M | 10.18M | 11.35M | 11.38M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 24.73M | 23.68M | 31.74M | 44.33M | 41.07M | 44.93M | 39.19M | 44.63M | 40.22M | 41.11M | 48.81M | 52.37M |
| Total liabilities | 30.37M | 28.80M | 35.35M | 40.03M | 37.01M | 41.76M | 36.04M | 40.42M | 34.73M | 32.77M | 35.11M | 32.57M |
| Cash and equivalents | 1.74M | 1.15M | 2.73M | 1.18M | 794.00K | 1.39M | 863.00K | 1.96M | 700.00K | 1.05M | 1.81M | 1.30M |
| Shareholder equity | -5.55M | -5.05M | -858.00K | 3.96M | 3.52M | 5.32M | 5.24M | 5.95M | 7.07M | 9.52M | 14.47M | 19.17M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 99.6% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.72M | -1.08M | -8.07M | -12.64M | -34.37M | -7.92M | -5.96M | -431.00K | 525.00K | 0 |
| Capital expenditures | 13.00K | 156.00K | 581.00K | 1.56M | 4.59M | 2.71M | 1.55M | 729.00K | 426.00K | 0 |
| Free cash flow | 4.70M | -1.23M | -8.66M | -14.20M | -38.97M | -10.63M | -7.51M | -1.16M | 99.00K | 0 |
| Investing cash flow | -531.00K | -470.00K | -1.18M | -1.41M | -9.01M | -4.08M | -3.77M | -729.00K | -426.00K | N/A |
| Financing cash flow | 1.15M | 3.83M | 9.42M | 4.76M | 48.73M | 6.74M | 17.05M | 79.23K | 100.00K | 0 |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.32M | -186.00K | 2.64M | -3.50M | -474.00K | 4.46M | -4.20M | 2.75M | 387.00K | -629.00K | -218.00K | 5.36M |
| Capital expenditures | 980 | 5.00K | 3.52K | 4.00K | 2.89K | 0 | 30.00K | 74.00K | 50.00K | 2.00K | 28.00K | 1.08K |
| Free cash flow | -1.32M | -191.00K | 2.63M | -3.50M | -476.89K | 4.46M | -4.23M | 2.68M | 337.00K | -631.00K | -246.00K | 5.35M |
Frequently Asked Questions About IMCC
What is Im Cannabis' annual revenue?
Im Cannabis reported revenue of CAD 54.73M for the fiscal year ended Dec 31, 2025.
How fast is Im Cannabis' revenue growing?
Revenue was up 1.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.2%.
Is Im Cannabis profitable?
No. Im Cannabis reported net income of CAD -11.32M for the fiscal year ended Dec 31, 2025, with a net margin of -20.7%.
How much free cash flow does IMCC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of CAD 4.72M minus capital expenditures of CAD 13.00K produced free cash flow of CAD 4.70M.
How much debt does Im Cannabis have?
The balance sheet dated Dec 31, 2025 reported long-term debt of CAD 936.00K, short-term debt of CAD 15.28M and cash and equivalents of CAD 2.73M.
IMCC pages: Overview, Financials